Hidradenitis Suppurativa Therapies for Skin of Color
Okay,here’s a breakdown of the key information from the provided text,focusing on Hidradenitis Suppurativa (HS) treatment and takeaways from a presentation by Dr. Mayo:
Key Treatment Points:
* Biologics: Three biologics are effective in treating HS, showing at least a 50% reduction in abscess nodules in 50% of patients:
* Adalimumab
* Secukinumab
* Bimekizumab (most recently approved)
* Pregnancy:
* Some antibiotics used for HS are pregnancy category B (no evidence of fetal harm in studies).
* Metformin and zinc supplements are used as part of a regimen for patients during pregnancy.
Key Takeaways from Dr. Mayo’s Presentation:
* Addressing Stigma: It’s crucial to tell patients:
* HS is not an infection.
* HS is not due to poor hygiene.
* Obesity is not the reason for HS.
* HS is not just a skin disease.
* HS is not the patient’s fault.
* Focus of Discussion: The presentation covered gaps in diagnosis, patient stigmas, comorbidities, adjuvant/combination therapies, and treatment strategies.
Additional Information:
* Prevalence: A study by Vinding et al.(2014) in the British Journal of Dermatology examined the prevalence of HS.
* Source of Information: The information is based on a presentation by Dr. Mayo at the Skin of Color Update conference (October 3-5, 2025, New York, NY).
* FDA Approvals: The text links to an article about recent FDA approvals expanding dermatology options for patients with skin of color: https://www.ajmc.com/view/recent-fda-approvals-expand-dermatology-options-for-patients-with-skin-of-color
* Cleveland Clinic Resource: A Cleveland Clinic resource on HS symptoms and treatments is also referenced.
Let me know if you’d like me to elaborate on any specific aspect of this information!